/ Professor

Fabulous:

Recommended Ph.D.Supervisor

Recommended MA Supervisor

  • -Supervisor of Doctorate Candidates

  • -Supervisor of Master's Candidates

  • -E-Mail:

  • -Date of Employment:2021-02

  • -School/Department:Shandong University, School of Basic Medical Sciences

  • -Administrative Position:Professor

  • -Education Level:Postgraduate (Postdoctoral)

  • -Business Address:School of Basic Medical Sciences, Shandong University

  • -Gender:Female

  • -Contact Information:

  • -Degree:Doctor

  • -Title:Professor

  • -Academic Titles:Deputy Chair of the Youth Committee, Chinese Electron Microscopy Society

  • -Other Post:Deputy Director, Medical Structural Biology Center

  • -Alma Mater:Tsinghua University

  • -Discipline:Biochemistry and Molecular Biology,Cell Biology,Biophysics,Genetics

Human ribosome interactions reframe neomycin toxicity

Release Time:2026-03-18 Hits:

Title of Paper:
Human ribosome interactions reframe neomycin toxicity
Journal:
bioRxiv 预印本ing
Summary:
Aminoglycosides like neomycin are widely used but clinically limited due to toxicity, traditionally attributed to mitoribosome inhibition. Here, we demonstrate that this assumption requires re-evaluation by comparing neomycin’s interactions with human ribosomes in vitro and in cells. While cryo-EM and biochemical assays reveal strong in vitro binding to both mitoribosomes and cytosolic ribosomes, especially at conserved regions such as the helix 44 (h44) decoding center despite sequence divergence, and H69. Cellular analyses show minimal impact on global translation, reduced occupancy on cytosolic ribosomes, and a complete absence of neomycin on mitoribosomes. These discrepancies suggest limited mitochondrial permeability rather than direct mitoribosome inhibition underlies neomycin’s toxicity. Our findings redefine the mechanistic basis of aminoglycosides side effects and call for a reassessment of their cellular targets.
Translation or Not:
No
Date of Publication:
2025-08
Links to Published Journals:
https://www.biorxiv.org/content/10.1101/2025.07.22.666027v3
Release Time:
2026-03-18